Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
DexCom
DXCM
5
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
US Stock MarketDetailed Quotes
PTPI Petros Pharmaceuticals
- 0.0629
- -0.0041-6.12%
Close Apr 7 16:00 ET
- 0.0616
- -0.0013-2.07%
Post 17:32 ET
3.37MMarket Cap-0.02P/E (TTM)
0.0660High0.0555Low4.90MVolume0.0620Open0.0670Pre Close295.24KTurnover9.87%Turnover RatioLossP/E (Static)53.52MShares0.900052wk High-0.45P/B3.12MFloat Cap0.054252wk Low--Dividend TTM49.67MShs Float59.5990Historical High--Div YieldTTM15.67%Amplitude0.0542Historical Low0.0600Avg Price1Lot Size
About Petros Pharmaceuticals Company
Petros Pharmaceuticals, Inc. engages in men's health therapeutics. It is involved in sales, marketing, regulatory and medical affairs, finance, trade relations, pharma co-vigilance, market access relations, manufacturing, and distribution. It operates through the Prescription Medications and Medical Devices segments. The Prescription Medications segment handles Stendra, an FDA approved PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction, and H100, a topical formulation candidate for the treatment of acute Peyronie's disease. The Medical Devices segment consists of vacuum erection devices. The company was founded on May 14, 2020 and is headquartered in New York, NY.
Company Profile
SymbolPTPI
Company NamePetros Pharmaceuticals
Listing DateDec 2, 2020
CEOMr. Fady Boctor, M.B.A.
MarketNASDAQ
Employees21
Fiscal Year Ends12-31
Address1185 Avenue of the Americas,3rd floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10036
Phone1-973-242-0005
Websitehttp://www.petrospharma.com
Company Executives
- Name
- Position
- Salary
- Mitchell Arnold
- Vice President, Finance and Chief Accounting Officer
- 488.25K
- Fady Boctor, M.B.A.
- President and Chief Commercial Officer
- 875.10K
- Joshua Nathaniel Silverman
- Chairman of the Board
- 309.30K
- Wayne R. Walker
- Independent Director
- 147.97K
- Bruce T. Bernstein
- Independent Director
- 147.97K
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now